BioHarvest Sciences (BHST) Competitors $12.65 +0.62 (+5.15%) As of 10/15/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BHST vs. ERAS, SVRA, IVA, MNPR, ARCT, KALV, BCYC, NAGE, ESPR, and OPTShould you be buying BioHarvest Sciences stock or one of its competitors? The main competitors of BioHarvest Sciences include Erasca (ERAS), Savara (SVRA), Inventiva (IVA), Monopar Therapeutics (MNPR), Arcturus Therapeutics (ARCT), KalVista Pharmaceuticals (KALV), Bicycle Therapeutics (BCYC), Niagen Bioscience (NAGE), Esperion Therapeutics (ESPR), and Opthea (OPT). These companies are all part of the "pharmaceutical products" industry. BioHarvest Sciences vs. Its Competitors Erasca Savara Inventiva Monopar Therapeutics Arcturus Therapeutics KalVista Pharmaceuticals Bicycle Therapeutics Niagen Bioscience Esperion Therapeutics Opthea Erasca (NASDAQ:ERAS) and BioHarvest Sciences (NASDAQ:BHST) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership. Is ERAS or BHST more profitable? Erasca has a net margin of 0.00% compared to BioHarvest Sciences' net margin of -39.95%. Erasca's return on equity of -31.19% beat BioHarvest Sciences' return on equity.Company Net Margins Return on Equity Return on Assets ErascaN/A -31.19% -26.34% BioHarvest Sciences -39.95%-11,357.84%-39.94% Do analysts recommend ERAS or BHST? Erasca currently has a consensus price target of $3.75, suggesting a potential upside of 50.60%. BioHarvest Sciences has a consensus price target of $13.67, suggesting a potential upside of 8.04%. Given Erasca's higher probable upside, equities research analysts clearly believe Erasca is more favorable than BioHarvest Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Erasca 2 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.38BioHarvest Sciences 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has better earnings & valuation, ERAS or BHST? BioHarvest Sciences has higher revenue and earnings than Erasca. BioHarvest Sciences is trading at a lower price-to-earnings ratio than Erasca, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioErascaN/AN/A-$161.65M-$0.45-5.53BioHarvest Sciences$25.19M8.25-$12.91M-$0.70-18.07 Does the media prefer ERAS or BHST? In the previous week, Erasca had 1 more articles in the media than BioHarvest Sciences. MarketBeat recorded 3 mentions for Erasca and 2 mentions for BioHarvest Sciences. BioHarvest Sciences' average media sentiment score of 0.83 beat Erasca's score of 0.64 indicating that BioHarvest Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Erasca 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioHarvest Sciences 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals hold more shares of ERAS or BHST? 67.8% of Erasca shares are owned by institutional investors. 14.4% of Erasca shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more volatility and risk, ERAS or BHST? Erasca has a beta of 1.18, meaning that its stock price is 18% more volatile than the S&P 500. Comparatively, BioHarvest Sciences has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500. SummaryErasca beats BioHarvest Sciences on 11 of the 15 factors compared between the two stocks. Get BioHarvest Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for BHST and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BHST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BHST vs. The Competition Export to ExcelMetricBioHarvest SciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$197.59M$3.36B$6.11B$10.45BDividend YieldN/A2.30%5.73%4.77%P/E Ratio-18.0722.7785.4027.36Price / Sales8.25483.38599.20137.65Price / CashN/A46.7037.4661.86Price / Book158.1310.5512.446.81Net Income-$12.91M-$52.58M$3.32B$276.80M7 Day Performance5.15%0.09%0.60%0.42%1 Month Performance45.07%15.61%10.53%7.86%1 Year PerformanceN/A15.13%73.12%41.24% BioHarvest Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BHSTBioHarvest Sciences1.6722 of 5 stars$12.65+5.2%$13.67+8.0%N/A$197.59M$25.19M-18.07N/AERASErasca2.4254 of 5 stars$2.42+13.6%$3.71+53.5%-11.4%$604.22MN/A-5.38120Analyst ForecastHigh Trading VolumeSVRASavara3.0376 of 5 stars$3.49flat$7.50+114.9%-1.4%$603.20MN/A-6.9820Analyst UpgradeIVAInventiva3.238 of 5 stars$6.53+3.7%$15.57+138.5%+112.0%$602.67M$9.95M0.00100Analyst RevisionMNPRMonopar Therapeutics2.689 of 5 stars$99.39+2.2%$90.44-9.0%+1,655.7%$599.78MN/A-29.8510Analyst ForecastARCTArcturus Therapeutics3.0435 of 5 stars$22.56+3.1%$50.57+124.2%+2.9%$594.14M$152.31M-10.12180Analyst UpgradeGap DownHigh Trading VolumeKALVKalVista Pharmaceuticals3.7449 of 5 stars$11.85+0.9%$26.43+123.0%-0.3%$593.65M$1.43M-3.01100BCYCBicycle Therapeutics3.9214 of 5 stars$8.37-1.9%$22.22+165.5%-69.0%$591.19M$19.28M-2.38240News CoverageAnalyst ForecastNAGENiagen Bioscience3.0728 of 5 stars$6.93-6.1%$13.42+93.7%N/A$588.58M$99.60M33.00120ESPREsperion Therapeutics3.6903 of 5 stars$3.30+13.8%$7.00+112.1%+18.3%$584.71M$332.31M-6.73200High Trading VolumeOPTOpthea0.4213 of 5 stars$3.41+7.2%$1.33-60.9%-30.5%$583.10M$30K0.008News CoveragePositive NewsAnalyst ForecastGap UpHigh Trading Volume Related Companies and Tools Related Companies Erasca Competitors Savara Competitors Inventiva Competitors Monopar Therapeutics Competitors Arcturus Therapeutics Competitors KalVista Pharmaceuticals Competitors Bicycle Therapeutics Competitors Niagen Bioscience Competitors Esperion Therapeutics Competitors Opthea Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BHST) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredBuy this stock before Tesla’s November 6 announcementThe End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioHarvest Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioHarvest Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
